Brief: Lee's Pharmaceutical Says Qtrly Profit Attributable HK$8.2 Mln
Aug 26 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* QTRLY PROFIT ATTRIBUTABLE HK$8.2 MILLION VERSUS HK$2.11
BILLION
* INTERIM DIVIDEND DECLARED IS HK$0.010 PER SHARE
* QTRLY REVENUE HK$324.4 MILLION VERSUS HK$300.9 MILLION
Source text for Eikon: ID:
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA